logo
logo

Endologix Appoints Andrew Davis As Chief Commercial Officer

Mar 05, 20255 months ago

Position

Chief Commercial Officer

Company

Endologix

Andrew Davis
IrvineMedicalBiotechnologyHealth Care

Description

Endologix LLC is pleased to announce the appointment of Andrew Davis as its new Chief Commercial Officer, effective immediately. Andrew brings over 25 years of experience in the medical device field, with expertise in commercial leadership, revenue optimization, customer engagement, and market expansion.

Company Information

Company

Endologix

Location

Irvine, California, United States

About

Endologix LLC is a California-based, global medical device company dedicated to improving patients’ lives by providing innovative therapies for the interventional treatment of vascular disease. We have a therapeutic portfolio designed to treat diseases which currently have clinically relevant unmet needs. Our existing products can treat a wide spectrum of vascular disease through abdominal aortic aneurysms to lower limb peripheral vascular disease. We obtain excellent clinical outcomes through meticulous attention to product design, manufacturing, and training, all backed by industry-leading clinical evidence. With a robust pipeline of disruptive technology, our vision is to provide physicians with the best device for each patient; because when it comes to ensuring patient well-being, we are never satisfied with the status quo.

Related People

Sign in to view contact details

Sign in to view contact details

Sign in to view contact details

Executive Insights

Based on hiring data
New executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months